Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2014-01-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anxiety Depression and Rheumatoid Arthritis
NCT03061877
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Rheumatoid Arthritis Patients
NCT05957770
Evaluation of Mood Disorders Under Biologics in Chronic Inflammatory Rheumatic Disease
NCT04817072
Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients
NCT04378621
A Causal Relationship Study Between Anxiety, Depression, and Rheumatoid Arthritis
NCT05892562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients RA-BIO
Patients with rheumatoid arthritis treated with biological drugs (infliximab, adalimumab, etanercept, abatacept, tocilizumab, golimumab, certolizumab, rituximab)
Hospital Anxiety and Depression Scale (HADS) questionnaire
Patients filled in the Hospital Anxiety and Depression Scale (HADS) questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hospital Anxiety and Depression Scale (HADS) questionnaire
Patients filled in the Hospital Anxiety and Depression Scale (HADS) questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of rheumatoid arthritis according to 2010 Classification American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR) Criteria
* being able to compile questionnaire
* current treatment with biological disease-modifying antirheumatic drug
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pavia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vittorio Grosso
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberto Caporali, MD
Role: STUDY_DIRECTOR
University of Pavia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS policlinico San Matteo - Reparto di Reumatologia
Pavia, PV, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31748\2009 progetto lorhen
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.